Aibotics Inc. (AIBT)

Aibotics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue	0	-	-	-	-
Gross Profit	0	-	-	-	-
Selling, General & Admin	1.85	1.63	0.62	1.74	4.99
Operating Expenses	1.85	1.63	0.62	1.74	4.99
Operating Income	-1.84	-1.63	-0.62	-1.74	-4.99
Interest Expense	-0.23	-0.21	-0.56	-0.87	-0.15
Other Non Operating Income (Expenses)	-	-	-	-0.01	-
EBT Excluding Unusual Items	-2.07	-1.85	-1.18	-2.61	-5.14
Other Unusual Items	-0.14	-	-	-	-
Pretax Income	-2.22	-1.85	-1.18	-2.61	-5.14
Earnings From Continuing Operations	-2.22	-1.85	-1.18	-2.61	-5.14
Net Income	-2.22	-1.85	-1.18	-2.61	-5.14
Net Income to Common	-2.22	-1.85	-1.18	-2.61	-5.14
Shares Outstanding (Basic)	186	13	15	14	13
Shares Outstanding (Diluted)	186	13	15	14	13
Shares Change (YoY)	1291.99%	-10.09%	3.04%	7.70%	7.95%
EPS (Basic)	-0.01	-0.14	-0.08	-0.18	-0.38
EPS (Diluted)	-0.01	-0.14	-0.08	-0.18	-0.38
Free Cash Flow	-0.46	-0.26	-0.11	-0.66	-0.24
Free Cash Flow Per Share	-0.00	-0.02	-0.01	-0.04	-0.02
Gross Margin	100.00%	-	-	-	-
Operating Margin	-84501.74%	-	-	-	-
Profit Margin	-101500.27%	-	-	-	-
Free Cash Flow Margin	-20991.30%	-	-	-	-
EBITDA	-1.18	-0.97	-0.56	-1.74	-4.99
D&A For EBITDA	0.67	0.67	0.06	0	0
EBIT	-1.84	-1.63	-0.62	-1.74	-4.99

Source: S&P Global Market Intelligence. Standard template. Financial Sources.